NCT00303550View on ClinicalTrials.gov

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2006

Conditions
Skin Diseases, Bacterial
Interventions
DRUG

Intravenous iclaprim

DRUG

Intravenous linezolid

Trial Locations (2)

60540

Edward Hospital & Health Services, Naperville

82601

Wyoming Medical Center, Casper

Sponsors

Lead Sponsor

Arpida AG
All Listed Sponsors
lead

Arpida AG

INDUSTRY

NCT00303550 - Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2) | Biotech Hunter | Biotech Hunter